Board to consider Dividend
Indraprastha Medical Corporation Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 20, 2016, inter alia:-1. to consider and approve, the audited financial results for the quarter/ year ended March 31, 2016, and 2. to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2015-16.... Shareholding for the Period Ended March 31, 2016
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Indraprastha Medical Corporation Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Outcome of Board Meeting
Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2016, have:1. Re-appointed Dr. B. Venkataraman as Independent Director of the Company, for a period of 2 consecutive years effective from April 01, 2016 to March 31, 2018, subject to the approval of the shareholders of the Company;... Financial Results, Limited Review Report for December 31, 2015
Indraprastha Medical Corporation Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 2015 Shareholding for the Period Ended December 31, 2015
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Board Intimation for Results & Closure of Trading Window
Indraprastha Medical Corporation Ltd has informed BSE that the Trading Window shall remain closed from February 02, 2016 to February 12, 2016 (both days inclusive) in connection with the forthcoming Board meeting of the Company scheduled to be held on February 09, 2016, for declaration of financial results for the quarter and nine months ended December 31, 2015. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Indraprastha Medical Corporation Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Housing Development Finance Corporation Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Demise of Director
Indraprastha Medical Corporation Ltd has informed BSE that Prof. Ranjit Roy Chaudhury, Director of the Company, has passed away on October 27, 2015.